In a recent study, patients with Hypochondriasis were randomly assigned to either Cognitive Behavior Therapy (CBT), Paroxetine (i.e. Paxil) or a placebo. All patients completed a self-report measure prior to treatment, and after 16 weeks of treatment or placebo. Of the 82 patients who completed the course of treatment: 54% of patients who received CBT improved. 38% of patients who received Paroxetine improved. 12% of patients who received placebo improved. The team who completed the study reported that, "subjects appeared to be less frequently and intensively preoccupied with their fears of having a serious disease and also had less associated depressive, anxious, and psychoneurotic symptoms." Great news for patients with Hypochondriasis.